H L Tillmann
Overview
Explore the profile of H L Tillmann including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
96
Citations
1035
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Wiegand J, Luz B, Mengelkamp A, Moog R, Koscielny J, Halm-Heinrich I, et al.
J Viral Hepat
. 2009 Jun;
16(10):743-8.
PMID: 19486277
Prevalence data concerning viral hepatitis and human immunodeficiency virus (HIV) in the general population are usually scarce. We aimed for a large cohort representative of the general population that required...
22.
Heringlake S, Schutte A, Flemming P, Schmiegel W, Manns M, Tillmann H
Z Gastroenterol
. 2009 May;
47(5):417-23.
PMID: 19418409
Unlabelled: Aim was to investigate possible underlying causes of presumed cryptogenic liver disease. Methods: A cohort of 126 consecutive patients with presumed cryptogenic hepatitis referred to a university hospital were...
23.
Wiegand J, Mossner J, Tillmann H
Internist (Berl)
. 2008 Jun;
49(7):817-29.
PMID: 18548220
Therapy of chronic hepatitis B (HBV) und C (HCV) virus infection has continuously improved over the last years by the invention of new therapeutic agents for HBV, greater individualization for...
24.
Girke J, Wedemeyer H, Wiegand J, Manns M, Tillmann H
Dtsch Med Wochenschr
. 2008 May;
133(22):1178-82.
PMID: 18491273
Introduction: The efficiacy of Entecavir and Adefovir for treatment of acute hepatitis B is not known. History: Two women with severe acute hepatitis B (HB) complained about a skin rash...
25.
Lobstein S, Kaiser T, Liebert U, Wojan M, Leichtle A, Mossner J, et al.
Z Gastroenterol
. 2008 May;
46(5):415-20.
PMID: 18461515
Introduction: In a recent study on hepatitis C prevalence, we identified a high prevalence of elevated liver enzymes, well above 10 %, in orthopaedic surgery patients without evidence for viral...
26.
Ciesek S, Liermann H, Hadem J, Greten T, Tillmann H, Cornberg M, et al.
J Viral Hepat
. 2008 Feb;
15(3):200-11.
PMID: 18233993
Dendritic cells (DCs) play a central role in antiviral immunity. Conflicting data on DC function have been reported for hepatitis C virus (HCV) infection. In addition to antigen presentation and...
27.
Kubitschke A, Bader C, Tillmann H, Manns M, Kuhn S, Wedemeyer H
Internist (Berl)
. 2007 Aug;
48(10):1165-72.
PMID: 17684714
The risk of infection after injury with a needle contaminated with hepatitis C virus (HCV) is thought to be about 3%, but this assumption is mainly based on studies published...
28.
Pradat P, Tillmann H, Sauleda S, Braconier J, Saracco G, Thursz M, et al.
J Viral Hepat
. 2007 Jul;
14(8):556-63.
PMID: 17650289
The aims of the study were to verify the long-term effect of time on viral clearance in hepatitis C virus (HCV) patients and to find out factors possibly associated with...
29.
Wiegand J, Mossner J, Tillmann H
Internist (Berl)
. 2007 Jan;
48(2):154-63.
PMID: 17226007
Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) are the hepatic manifestations of the metabolic syndrome. Since the prevalence of obesity and consequently of the metabolic syndrome is steadily...
30.
Kubitschke A, Bahr M, Aslan N, Bader C, Tillmann H, Sarrazin C, et al.
Eur J Clin Invest
. 2006 Dec;
37(1):54-64.
PMID: 17181568
Background: The risk of hepatitis C virus (HCV) infection after occupational exposure is low with seroconversion rates between 0 and 5%. However, factors associated with natural resistance against HCV after...